These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 17475445

  • 1. Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor.
    Dudek SM, Camp SM, Chiang ET, Singleton PA, Usatyuk PV, Zhao Y, Natarajan V, Garcia JG.
    Cell Signal; 2007 Aug; 19(8):1754-64. PubMed ID: 17475445
    [Abstract] [Full Text] [Related]

  • 2. Junctional complex and focal adhesion rearrangement mediates pulmonary endothelial barrier enhancement by FTY720 S-phosphonate.
    Wang L, Bittman R, Garcia JG, Dudek SM.
    Microvasc Res; 2015 May; 99():102-9. PubMed ID: 25862132
    [Abstract] [Full Text] [Related]

  • 3. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.
    Finigan JH, Dudek SM, Singleton PA, Chiang ET, Jacobson JR, Camp SM, Ye SQ, Garcia JG.
    J Biol Chem; 2005 Apr 29; 280(17):17286-93. PubMed ID: 15710622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. "Pulmonary Endothelial Cell Barrier Enhancement by Novel FTY720 Analogs: Methoxy-FTY720, Fluoro-FTY720, and β-Glucuronide-FTY720".
    Camp SM, Chiang ET, Sun C, Usatyuk PV, Bittman R, Natarajan V, Garcia JG, Dudek SM.
    Chem Phys Lipids; 2016 Jan 29; 194():85-93. PubMed ID: 26496151
    [Abstract] [Full Text] [Related]

  • 10. FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
    Wang L, Chiang ET, Simmons JT, Garcia JG, Dudek SM.
    Eur Respir J; 2011 Jul 29; 38(1):78-88. PubMed ID: 21071472
    [Abstract] [Full Text] [Related]

  • 11. Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro.
    Camp SM, Bittman R, Chiang ET, Moreno-Vinasco L, Mirzapoiazova T, Sammani S, Lu X, Sun C, Harbeck M, Roe M, Natarajan V, Garcia JG, Dudek SM.
    J Pharmacol Exp Ther; 2009 Oct 29; 331(1):54-64. PubMed ID: 19592667
    [Abstract] [Full Text] [Related]

  • 12. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family.
    Singleton PA, Dudek SM, Ma SF, Garcia JG.
    J Biol Chem; 2006 Nov 10; 281(45):34381-93. PubMed ID: 16963454
    [Abstract] [Full Text] [Related]

  • 13. FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury.
    Wang L, Sammani S, Moreno-Vinasco L, Letsiou E, Wang T, Camp SM, Bittman R, Garcia JG, Dudek SM.
    Crit Care Med; 2014 Mar 10; 42(3):e189-99. PubMed ID: 24335440
    [Abstract] [Full Text] [Related]

  • 14. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids.
    Singleton PA, Chatchavalvanich S, Fu P, Xing J, Birukova AA, Fortune JA, Klibanov AM, Garcia JG, Birukov KG.
    Circ Res; 2009 Apr 24; 104(8):978-86. PubMed ID: 19286607
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase.
    Dudek SM, Jacobson JR, Chiang ET, Birukov KG, Wang P, Zhan X, Garcia JG.
    J Biol Chem; 2004 Jun 04; 279(23):24692-700. PubMed ID: 15056655
    [Abstract] [Full Text] [Related]

  • 16. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes.
    Singer II, Tian M, Wickham LA, Lin J, Matheravidathu SS, Forrest MJ, Mandala S, Quackenbush EJ.
    J Immunol; 2005 Dec 01; 175(11):7151-61. PubMed ID: 16301618
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
    Oo ML, Thangada S, Wu MT, Liu CH, Macdonald TL, Lynch KR, Lin CY, Hla T.
    J Biol Chem; 2007 Mar 23; 282(12):9082-9. PubMed ID: 17237497
    [Abstract] [Full Text] [Related]

  • 18. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
    LaMontagne K, Littlewood-Evans A, Schnell C, O'Reilly T, Wyder L, Sanchez T, Probst B, Butler J, Wood A, Liau G, Billy E, Theuer A, Hla T, Wood J.
    Cancer Res; 2006 Jan 01; 66(1):221-31. PubMed ID: 16397235
    [Abstract] [Full Text] [Related]

  • 19. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
    Butler J, Lana D, Round O, LaMontagne K.
    Prostaglandins Other Lipid Mediat; 2004 Jan 01; 73(1-2):29-45. PubMed ID: 15165029
    [Abstract] [Full Text] [Related]

  • 20. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning.
    Vessey DA, Li L, Imhof I, Honbo N, Karliner JS.
    Med Sci Monit Basic Res; 2013 Apr 09; 19():126-32. PubMed ID: 23567658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.